The DOI matches its Crossref record; 326 of the 326 references it cites were found in a registry or an index.
Antidepressants for smoking cessation
Open accessAbstract
BACKGROUND: There are at least three reasons to believe antidepressants might help in smoking cessation. Firstly, nicotine withdrawal may produce depressive symptoms or precipitate a major depressive episode and antidepressants may relieve these. Secondly, nicotine may have antidepressant effects that maintain smoking, and antidepressants may substitute for this effect. Finally, some antidepressants may have a specific effect on neural pathways (e.g. inhibiting monoamine oxidase) or receptors (e.g. blockade of nicotinic-cholinergic receptors) underlying nicotine addiction. OBJECTIVES: The aim of this review is to assess the effect and safety of antidepressant medications to aid long-term smoking cessation. The medications include bupropion; doxepin; fluoxetine; imipramine; lazabemide; moclobemide; nortriptyline; paroxetine; S-Adenosyl-L-Methionine (SAMe); selegiline; sertraline; St. John's wort; tryptophan; venlafaxine; and zimeledine. SEARCH METHODS: We searched the Cochrane Tobacco Addiction Group Specialised Register which includes reports of trials indexed in the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and PsycINFO, and other reviews and meeting abstracts, in July 2013. SELECTION CRITERIA: We considered randomized trials comparing antidepressant medications to placebo or an alternative pharmacotherapy for smoking cessation. We also included trials comparing different doses, using pharmacotherapy to prevent relapse or re-initiate smoking cessation or to help smokers reduce cigarette consumption. We excluded trials with less than six months follow-up. DATA COLLECTION AND ANALYSIS: We extracted data and assessed risk of bias using standard methodological procedures expected by the Cochrane Collaboration.The main outcome measure was abstinence from smoking after at least six months follow-up in patients smoking at baseline, expressed as a risk ratio (RR). We used the most rigorous definition of abstinence available in each trial, and biochemically validated rates if available. Where appropriate, we performed meta-analysis using a fixed-effect model. MAIN RESULTS: Twenty-four new trials were identified since the 2009 update, bringing the total number of included trials to 90. There were 65 trials of bupropion and ten trials of nortriptyline, with the majority at low or unclear risk of bias. There was high quality evidence that, when used as the sole pharmacotherapy, bupropion significantly increased long-term cessation (44 trials, N = 13,728, risk ratio [RR] 1.62, 95% confidence interval [CI] 1.49 to 1.76). There was moderate quality evidence, limited by a relatively small number of trials and participants, that nortriptyline also significantly increased long-term cessation when used as the sole pharmacotherapy (six trials, N = 975, RR 2.03, 95% CI 1.48 to 2.78). There is insufficient evidence that adding bupropion (12 trials, N = 3487, RR 1.9, 95% CI 0.94 to 1.51) or nortriptyline (4 trials, N = 1644, RR 1.21, 95% CI 0.94 to 1.55) to nicotine replacement therapy (NRT) provides an additional long-term benefit. Based on a limited amount of data from direct comparisons, bupropion and nortriptyline appear to be equally effective and of similar efficacy to NRT (bupropion versus nortriptyline 3 trials, N = 417, RR 1.30, 95% CI 0.93 to 1.82; bupropion versus NRT 8 trials, N = 4096, RR 0.96, 95% CI 0.85 to 1.09; no direct comparisons between nortriptyline and NRT). Pooled results from four trials comparing bupropion to varenicline showed significantly lower quitting with bupropion than with varenicline (N = 1810, RR 0.68, 95% CI 0.56 to 0.83). Meta-analyses did not detect a significant increase in the rate of serious adverse events amongst participants taking bupropion, though the confidence interval only narrowly missed statistical significance (33 trials, N = 9631, RR 1.30, 95% CI 1.00 to 1.69). There is a risk of about 1 in 1000 of seizures associated with bupropion use. Bupropion has been associated with suicide risk, but whether this is causal is unclear. Nortriptyline has the potential for serious side-effects, but none have been seen in the few small trials for smoking cessation.There was no evidence of a significant effect for selective serotonin reuptake inhibitors on their own (RR 0.93, 95% CI 0.71 to 1.22, N = 1594; 2 trials fluoxetine, 1 paroxetine, 1 sertraline) or as an adjunct to NRT (3 trials of fluoxetine, N = 466, RR 0.70, 95% CI 0.64 to 1.82). Significant effects were also not detected for monoamine oxidase inhibitors (RR 1.29, 95% CI 0.93 to 1.79, N = 827; 1 trial moclobemide, 5 selegiline), the atypical antidepressant venlafaxine (1 trial, N = 147, RR 1.22, 95% CI 0.64 to 2.32), the herbal therapy St John's wort (hypericum) (2 trials, N = 261, RR 0.81, 95% CI 0.26 to 2.53), or the dietary supplement SAMe (1 trial, N = 120, RR 0.70, 95% CI 0.24 to 2.07). AUTHORS' CONCLUSIONS: The antidepressants bupropion and nortriptyline aid long-term smoking cessation. Adver
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,464
Self-citationA controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400903 · Cited by 1,585
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation
Hurt, R. D., Sachs, D. P. L., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., Khayrallah, M. A., Schroeder, D. R., Glover, P. N., Sullivan, C. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710233371703 · Cited by 1,261
Pharmacological interventions for smoking cessation: an overview and network meta-analysis
Cahill, K., Stevens, S., Perera, R., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009329.pub2 · Cited by 1,243
Self-citationSmoking cessation guidelines for health professionals: an update
West, R. (2000) · Thorax · doi:10.1136/thorax.55.12.987 · Cited by 982
Nicotine receptor partial agonists for smoking cessation
Cahill, K., Stead, L., & Lancaster, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub2 · Cited by 747
Self-citationAntidepressants for smoking cessation
Hughes, Jr., Stead, L., & Lancaster, T. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031 · Cited by 681
Self-citationAntidepressants for smoking cessation
Hughes, J. R., Stead, L. F., & Lancaster, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub3 · Cited by 567
Self-citationRelapse prevention interventions for smoking cessation
Hajek, P., Stead, L. F., West, R., Jarvis, M., Hartmann-Boyce, J., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003999.pub4 · Cited by 467
Self-citationTashkin, D., Kanner, R., Bailey, W., Buist, S., Anderson, P., Nides, M., Gonzales, D., Dozier, G., Patel, M., & Jamerson, B. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04724-3 · Cited by 413
Nides, M. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1561 · Cited by 390
Nortriptyline and Cognitive-Behavioral Therapy in the Treatment of Cigarette Smoking
Hall, S. M., Reus, V. I., Muñoz, R. F., Sees, K. L., Humfleet, G., Hartz, D. T., Frederick, S., & Triffleman, E. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.8.683 · Cited by 385
Hays, J. T., Hurt, R. D., Rigotti, N. A., Niaura, R., Gonzales, D., Durcan, M. J., Sachs, D. P. L., Wolter, T. D., Buist, A. S., Johnston, J. A., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00011 · Cited by 343
Side effects of antidepressants: an overview.
Khawam, E. A., Laurencic, G., & Malone, D. A. (2006) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.73.4.351 · Cited by 305
A placebo controlled trial of bupropion for smoking cessation in schizophrenia
George, T. P., Vessicchio, J. C., Termine, A., Bregartner, T. A., Feingold, A., Rounsaville, B. J., & Kosten, T. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01339-2 · Cited by 292
Fryer, J. D., & Lukas, R. J. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37928-5 · Cited by 283
Hayford, K. E., Patten, C. A., Rummans, T. A., Schroeder, D. R., Offord, K. P., Croghan, I. T., Glover, E. D., Sachs, D. P. L., & Hurt, R. D. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.174.2.173 · Cited by 264
The effect of bupropion on nicotine craving and withdrawal
Shiffman, S., Johnston, J. A., Khayrallah, M., Elash, C. A., Gwaltney, C. J., Paty, J. A., Gnys, M., Evoniuk, G., & DeVeaugh-Geiss, J. (2000) · Psychopharmacology · doi:10.1007/s002130050022 · Cited by 259
Scharf, D., & Shiffman, S. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00845.x · Cited by 255
Tonstad, S. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00003-4 · Cited by 246
A Randomized Placebo-Controlled Clinical Trial of 5 Smoking Cessation Pharmacotherapies
Piper, M. E., Smith, S. S., Schlam, T. R., Fiore, M. C., Jorenby, D. E., Fraser, D., & Baker, T. B. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.142 · Cited by 246
Ahluwalia, J. S., Harris, K. J., Catley, D., Okuyemi, K. S., & Mayo, M. S. (2002) · JAMA · doi:10.1001/jama.288.4.468 · Cited by 244
Smoking cessation in severe mental illness: what works?
Banham, L., & Gilbody, S. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.02946.x · Cited by 243
Gepner, A. D., Piper, M. E., Johnson, H. M., Fiore, M. C., Baker, T. B., & Stein, J. H. (2011) · American Heart Journal · doi:10.1016/j.ahj.2010.09.023 · Cited by 242
Molecular Genetics of Successful Smoking Cessation: Convergent Genome-Wide Association Study Results
Uhl, G. R., Liu, Q.-R., Drgon, T., Johnson, C., Walther, D., Rose, J. E., David, S. P., Niaura, R., & Lerman, C. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.6.683 · Cited by 237
Smoking and suicide: A brief overview
Hughes, J. R. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.06.003 · Cited by 236
Self-citationPregnancy outcome of women exposed to bupropion during pregnancy: A prospective comparative study
Chun-Fai-Chan, B., Koren, G., Fayez, I., Kalra, S., Voyer-Lavigne, S., Boshier, A., Shakir, S., & Einarson, A. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.09.027 · Cited by 234
Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers
Naranjo, C. A., Kadlec, K. E., Sanhueza, P., Woodley-Remus, D., & Sellers, E. M. (1990) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1990.62 · Cited by 224
Cryan, J. F., Bruijnzeel, A. W., Skjei, K. L., & Markou, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1445-7 · Cited by 223
Piper, M. E., Cook, J. W., Schlam, T. R., Jorenby, D. E., Smith, S. S., Bolt, D. M., & Loh, W.-Y. (2010) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq067 · Cited by 206
West, R., Baker, C. L., Cappelleri, J. C., & Bushmakin, A. G. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1041-3 · Cited by 203
Evins, A. E., Cather, C., Deckersbach, T., Freudenreich, O., Culhane, M. A., Olm-Shipman, C. M., Henderson, D. C., Schoenfeld, D. A., Goff, D. C., & Rigotti, N. A. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000162802.54076.18 · Cited by 203
Gifford, E. V., Kohlenberg, B. S., Hayes, S. C., Pierson, H. M., Piasecki, M. P., Antonuccio, D. O., & Palm, K. M. (2011) · Behavior Therapy · doi:10.1016/j.beth.2011.03.002 · Cited by 200
Lerman, C., Jepson, C., Wileyto, E. P., Epstein, L. H., Rukstalis, M., Patterson, F., Kaufmann, V., Restine, S., Hawk, L., Niaura, R., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300861 · Cited by 197
A Randomized Trial of Nortriptyline for Smoking Cessation
Prochazka, A. V., Weaver, M. J., Keller, R. T., Fryer, G. E., Licari, P. A., & Lofaso, D. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.18.2035 · Cited by 193
Evins, A. E., Mays, V. K., Rigotti, N. A., Tisdale, T., Cather, C., & Goff, D. C. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200110073920 · Cited by 191
Psychological Intervention and Antidepressant Treatment in Smoking Cessation
Hall, S. M., Humfleet, G. L., Reus, V. I., Muñoz, R. F., Hartz, D. T., & Maude-Griffin, R. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.930 · Cited by 191
Piper, M. E., Cook, J. W., Schlam, T. R., Jorenby, D. E., & Baker, T. B. (2011) · Addiction · doi:10.1111/j.1360-0443.2010.03173.x · Cited by 189
Hall, S. M., Delucchi, K. L., Velicer, W. F., Kahler, C. W., Ranger-Moore, J., Hedeker, D., Tsoh, J. Y., & Niaura, R. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200110050411 · Cited by 188
Patterson, F., Schnoll, R., Wileyto, E., Pinto, A., Epstein, L., Shields, P., Hawk, L., Tyndale, R., Benowitz, N., & Lerman, C. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.57 · Cited by 181
Dunner, D. L., Zisook, S., Billow, A. A., Batey, S. R., Johnston, J. A., & Ascher, J. A. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0705 · Cited by 180
Evins, A. E., Cather, C., Culhane, M. A., Birnbaum, A., Horowitz, J., Hsieh, E., Freudenreich, O., Henderson, D. C., Schoenfeld, D. A., Rigotti, N. A., et al. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0b013e3180ca86fa · Cited by 179
Pharmacogenetic investigation of smoking cessation treatment
Lerman, C., Shields, P. G., Wileyto, E. P., Audrain, J., Pinto, A., Hawk, L., Krishnan, S., Niaura, R., & Epstein, L. (2002) · Pharmacogenetics · doi:10.1097/00008571-200211000-00007 · Cited by 178
Bupropion for Smoking Cessation
Dale, L. C., Glover, E. D., Sachs, D. P. L., Schroeder, D. R., Offord, K. P., Croghan, I. T., & Hurt, R. D. (2001) · Chest · doi:10.1378/chest.119.5.1357 · Cited by 177
Nicotine receptor partial agonists for smoking cessation
Cahill, K., Stead, L. F., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub6 · Cited by 177
Self-citationAntidepressants for smoking cessation
Hughes, Jr., Stead, L., & Lancaster, T. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub2 · Cited by 172
Self-citationRandomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence
SHOPTAW, S. J., Heinzerling, K. G., Rotheram-Fuller, E. J., Steward, T., Wang, J., Swanson, A., Garza, R. D. L., Newton, T., & Ling, W. W. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.03.010 · Cited by 169
Piper, M. E., Kenford, S. L., Fiore, M. C., & Baker, T. B. (2011) · Annals of Behavioral Medicine · doi:10.1007/s12160-011-9329-2 · Cited by 169
Interventions for smokeless tobacco use cessation
Ebbert, J. O., Elrashidi, M. Y., & Stead, L. F. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004306.pub5 · Cited by 168
Self-citationToll, B. A., O’Malley, S. S., Katulak, N. A., Wu, R., Dubin, J. A., Latimer‐Cheung, A. E., Meandzija, B., George, T. P., Jatlow, P. I., Cooney, J. L., et al. (2007) · Psychology of Addictive Behaviors · doi:10.1037/0893-164x.21.4.534 · Cited by 164
Lerman, C. E., Shields, P. G., Wileyto, E. P., Audrain, J. E., Hawk, L. W., Pinto, A., Kucharski, S., Krishnan, S. S., NIAURA, R. S., & Epstein, L. H. (2003) · Health Psychology · doi:10.1037/0278-6133.22.5.541 · Cited by 163
Swan, G. E., McAfee, T. A., Curry, S. J., Jack, L. M., Javitz, H. S., Dacey, S., & Bergman, K. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.19.2337 · Cited by 163
Tønnesen, P., Tonstad, S., Hjalmarson, Å., Lebargy, F., van Spiegel, P. I., Hider, A., Sweet, R., & Townsend, J. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01185.x · Cited by 162
Berlin, I., Saïd, S., Spreux-Varoquaux, O., Launay, J.-M., Olivares, R., Millet, V., Lecrubier, Y., & Puech, A. J. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90058-6 · Cited by 160
George, T. P., Vessicchio, J. C., Sacco, K. A., Weinberger, A. H., Dudas, M. M., Allen, T. M., Creeden, C. L., Potenza, M. N., Feingold, A., & Jatlow, P. I. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.11.002 · Cited by 160
Smoking cessation interventions for smokers with current or past depression
van der Meer, R. M., Willemsen, M. C., Smit, F., & Cuijpers, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006102.pub2 · Cited by 159
Extended nortriptyline and psychological treatment for cigarette smoking
Hall, S. M., Humfleet, G. L., Reus, V. I., Muñoz, R. F., & Cullen, J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2100 · Cited by 158
Mediating mechanisms for the impact of bupropion in smoking cessation treatment
Lerman, C., Roth, D., Kaufmann, V., Audrain, J., Hawk, L., Liu, A., Niaura, R., & Epstein, L. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00067-4 · Cited by 155
Bupropion for Smokers Hospitalized with Acute Cardiovascular Disease
Rigotti, N. A., Thorndike, A. N., Regan, S., McKool, K. M., Pasternak, R. C., Chang, Y., Swartz, S. H., Torres-Finnerty, N., Emmons, K. M., & Singer, D. E. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.04.024 · Cited by 153
Influences of Mood, Depression History, and Treatment Modality on Outcomes in Smoking Cessation.
Haas, A. L., Muñoz, R. F., Humfleet, G. L., Reus, V. I., & Hall, S. M. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.4.563 · Cited by 153
Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch
Johnstone, E. C., Yudkin, P. L., Hey, K., Roberts, S. J., Welch, S. J. V., Murphy, M. F., Griffiths, S. N. E., & Walton, R. T. (2004) · Pharmacogenetics · doi:10.1097/00008571-200402000-00002 · Cited by 151
Suicidal Behavior and Depression in Smoking Cessation Treatments
Moore, T. J., Furberg, C. D., Glenmullen, J., Maltsberger, J. T., & Singh, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027016 · Cited by 150
Killen, J. D., Robinson, T. N., Ammerman, S., Hayward, C., Rogers, J., Stone, C., Samuels, D., Levin, S. K., Green, S., & Schatzberg, A. F. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.4.729 · Cited by 146
Message framing for smoking cessation: The interaction of risk perceptions and gender
Toll, B. A., Salovey, P., O’Malley, S. S., Mazure, C. M., Latimer‐Cheung, A. E., & McKee, S. A. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200701767803 · Cited by 145
Inhibition of CYP2D6 Activity by Bupropion
Kotlyar, M., Brauer, L. H., Tracy, T. S., Hatsukami, D. K., Harris, J., Bronars, C. A., & Adson, D. E. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000162805.46453.e3 · Cited by 144
Gonzales, D. H., Nides, M. A., Ferry, L. H., Kustra, R. P., Jamerson, B. D., Segall, N., Herrero, L. A., Krishen, A., Sweeney, A., Buaron, K., et al. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.115750 · Cited by 143
CYP2B6 Genotype Alters Abstinence Rates in a Bupropion Smoking Cessation Trial
Lee, A. M., Jepson, C., Hoffmann, E. B., Epstein, L. H., Hawk, L. W., Lerman, C. E., & Tyndale, R. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.005 · Cited by 139
Conti, D. V., Lee, W., Li, D., Liu, J., Van Den Berg, D., Thomas, P. D., Bergen, A. W., Swan, G. E., Tyndale, R. F., Benowitz, N. L., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn181 · Cited by 136
Cinciripini, P. M., Robinson, J. D., Karam-Hage, M., Minnix, J. A., Lam, C., Versace, F., Brown, V. L., Engelmann, J. M., & Wetter, D. W. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.678 · Cited by 136
Tobacco withdrawal components and their relations with cessation success
Piper, M. E., Schlam, T. R., Cook, J. W., Sheffer, M. A., Smith, S. S., Loh, W., Bolt, D. M., Kim, S.-Y., Kaye, J. T., Hefner, K. R., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2250-3 · Cited by 135
Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics
Smith, S. S. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.426 · Cited by 132
Extended treatment of older cigarette smokers
Hall, S. M., Humfleet, G. L., Muñoz, R. F., Reus, V. I., Robbins, J. A., & Prochaska, J. J. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02548.x · Cited by 131
King, D. P., Paciga, S. A., Pickering, E. H., Benowitz, N. L., Bierut, L. J., Conti, D. V., Kaprio, J. A., Lerman, C. E., & Park, P. W. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.232 · Cited by 129
Smoker Characteristics and Smoking-Cessation Milestones
Japuntich, S. J., Leventhal, A. M., Piper, M. E., Bolt, D. M., Roberts, L. J., Fiore, M. C., & Baker, T. B. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.11.016 · Cited by 127
Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR
Swan, G. E., Valdes, A. M., Ring, H. Z., Khroyan, T. V., Jack, L. M., Ton, C. C. T., Curry, S. J., & McAfee, T. A. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500281 · Cited by 124
Physical activity as a strategy for maintaining tobacco abstinence: A randomized trial
Prochaska, J. J., Hall, S. M., Humfleet, G. L., Muñoz, R. F., Reus, V. I., Gorecki, J. A., & Hu, D. (2008) · Preventive Medicine · doi:10.1016/j.ypmed.2008.05.006 · Cited by 122
The prevalence of weight concerns in a smoking abstinence clinical trial
Clark, M. M., Hurt, R. D., Croghan, I. T., Patten, C. A., Novotny, P. J., Sloan, J. A., Dakhil, S. R., Croghan, G. A., Wos, E. J., Rowland, K. M., et al. (2005) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.08.011 · Cited by 120
Thomas, K. H., Martin, R. M., Davies, N. M., Metcalfe, C., Windmeijer, F., & Gunnell, D. (2013) · BMJ · doi:10.1136/bmj.f5704 · Cited by 119
Siddiqi, K., Khan, A. Z., Ahmad, M., Dogar, O. F., Kanaan, M. N., Newell, J. N., & Thomson, H. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-9-201305070-00006 · Cited by 118
How does bupropion work as a smoking cessation aid?
Warner, C., & Shoaib, M. (2005) · Addiction Biology · doi:10.1080/13556210500222670 · Cited by 115
Nortriptyline for smoking cessation: A review
Hughes, J. R., Stead, L. F., & Lancaster, T. (2005) · Nicotine & Tobacco Research · doi:10.1080/14622200500185298 · Cited by 115
Self-citationThe effect of bupropion sustained-release on cigarette craving after smoking cessation
Durcan, M. J., Deener, G., White, J., Johnston, J. A., Gonzales, D. H., NIAURA, R. S., Rigotti, N. A., & Sachs, D. P. L. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85130-x · Cited by 115
Bupropion for Smoking Cessation in Patients Hospitalized With Acute Myocardial Infarction
Eisenberg, M. J., Grandi, S. M., Gervais, A., O’Loughlin, J. L., Paradis, G., Rinfret, S., Sarrafzadegan, N., Sharma, S., Lauzon, C., Yadav, R. K., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1030 · Cited by 113
Bupropion and cognitive-behavioral treatment for depression in smoking cessation
Brown, R. A., NIAURA, R. S., Lloyd‐Richardson, E. E., Strong, D. R., Kahler, C. W., Abrantes, A. M., Abrams, D. B., & Miller, I. W. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701416955 · Cited by 111
Using mediational models to explore the nature of tobacco motivation and tobacco treatment effects.
Piper, M. E., Federman, E. B., McCarthy, D. E., Bolt, D. M., Smith, S. S., Fiore, M. C., & Baker, T. B. (2008) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.117.1.94 · Cited by 111
Clinical Efficacy of Bupropion in the Management of Smoking Cessation
Jorenby, D. E. (2002) · Drugs · doi:10.2165/00003495-200262002-00003 · Cited by 109
Self-efficacy and motivation to quit during participation in a smoking cessation program
Boardman, T., Catley, D., Mayo, M. S., & Ahluwalia, J. S. (2005) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm1204_7 · Cited by 109
Antidepressant pharmacotherapy helps some cigarette smokers more than others.
Hitsman, B. L., Pingitore, R., Spring, B. J., Mahableshwarkar, A. R., Mizes, J. S., Segraves, K. B., Kristeller, J. L., & Xu, W. (1999) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.67.4.547 · Cited by 109
Hertzberg, M. A., Moore, S. D., Feldman, M. E., & Beckham, J. C. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00017 · Cited by 109
Does menthol attenuate the effect of bupropion among African American smokers?
Okuyemi, K. S., Ahluwalia, J. S., Ebersole‐Robinson, M., Catley, D., Mayo, M. S., & Resnicow, K. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00443.x · Cited by 108
Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation
David, S. P., Brown, R. A., Papandonatos, G. D., Kahler, C. W., Lloyd‐Richardson, E. E., Munafo, M. R., Shields, P. G., Lerman, C. E., Strong, D. R., McCaffery, J. M., et al. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701382033 · Cited by 107
Effects of bupropion on simulated demand for cigarettes and the subjective effects of smoking
Madden, G. J., & Kalman, D. (2010) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq018 · Cited by 106
A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation
George, T. P., Vessicchio, J. C., Termine, A., Jatlow, P. I., Kosten, T. R., & O’Malley, S. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01454-3 · Cited by 106
Doxepin as an adjunct to smoking cessation: a double-blind pilot study
Edwards, N. B., Murphy, J. K., Downs, A. D., Ackerman, B. J., & Rosenthal, T. L. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.3.373 · Cited by 105
Development of Major Depressive Disorder During Smoking-Cessation Treatment
Murphy, C., & Abrams, D. B. (1996) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v57n1106 · Cited by 105
Psychological mediators of bupropion sustained‐release treatment for smoking cessation
McCarthy, D. E., Piasecki, T. M., Lawrence, D. L., Jorenby, D. E., Shiffman, S. S., & Baker, T. B. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02275.x · Cited by 105
Hays, J. T., Leischow, S. J., Lawrence, D., & Lee, T. C. (2010) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq047 · Cited by 105
Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers
Gourlay, S. G., Forbes, A., Forbes, A., Marriner, T., Pethica, D., & McNeil, J. J. (1995) · BMJ · doi:10.1136/bmj.311.7001.363 · Cited by 104
Successful recruitment of minorities into clinical trials: The Kick It at Swope project.
Harris, K., Ahluwalia, J., Catley, D., Okuyemi, K., Mayo, M., & Resnicow, K. (2003) · Nicotine & Tobacco Research · doi:10.1080/1462220031000118540 · Cited by 103
Weiner, E., Ball, M. P., Summerfelt, A. T., Gold, J. M., & Buchanan, R. W. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.4.635 · Cited by 103
Depression during tobacco abstinence
Hughes, J. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701243185 · Cited by 97
Self-citationLeeman, R. F., McKee, S. A., Toll, B. A., Krishnan‐Sarin, S., Cooney, J. L., Makuch, R., & O’Malley, S. S. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200802443742 · Cited by 97
A Randomized Trial of Sertraline as a Cessation Aid for Smokers With a History of Major Depression
Covey, L. S., Glassman, A. H., Stetner, F., Rivelli, S. K., & Stage, K. B. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1731 · Cited by 97
Sarginson, J. E., Killen, J. D., Lazzeroni, L. C., Fortmann, S. P., Ryan, H. S., Schatzberg, A. F., & Murphy, G. M. (2011) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31155 · Cited by 96
Depressive Symptoms and Smoking Cessation After Hospitalization for Cardiovascular Disease
Thorndike, A. N., Regan, S., McKool, K., Pasternak, R. C., Swartz, S., Torres-Finnerty, N., & Rigotti, N. A. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.60 · Cited by 96
Asthana, A., Johnson, H. M., Piper, M. E., Fiore, M. C., Baker, T. B., & Stein, J. H. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.06.006 · Cited by 96
Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment.
NIAURA, R. S., Spring, B. J., Borrelli, B., Hedeker, D., Goldstein, M. G., Keuthen, N. J., DePue, J. D., Kristeller, J. L., Ockene, J., Prochazka, A. V., et al. (2002) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.70.4.887 · Cited by 96
Efficacy of confronting smokers with airflow limitation for smoking cessation
Kotz, D., Wesseling, G., Huibers, M. J. H., & van Schayck, O. C. P. (2009) · European Respiratory Journal · doi:10.1183/09031936.00116308 · Cited by 95
Berrettini, W. H., Wileyto, E. P., Epstein, L. H., Restine, S., Hawk, L. W., Shields, P. G., NIAURA, R. S., & Lerman, C. E. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.030 · Cited by 95
Bupropion for Smoking Cessation in African American Light Smokers: A Randomized Controlled Trial
Cox, L. S., Nollen, N. L., Mayo, M. S., Choi, W. S., Faseru, B., BENOWITZ, N., Tyndale, R. F., Okuyemi, K. S., & Ahluwalia, J. S. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr513 · Cited by 94
Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinence
Jatlow, P. I., Toll, B. A., Leary, V., Krishnan‐Sarin, S., & O’Malley, S. S. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.05.013 · Cited by 93
Smith, S. S., Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Jamerson, B. D., Fiore, M. C., & Baker, T. (2003) · Nicotine & Tobacco Research · doi:10.1080/1462220021000060437 · Cited by 92
A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling
McCarthy, D. E., Piasecki, T. M., Lawrence, D. L., Jorenby, D. E., Shiffman, S. M., Fiore, M. C., & Baker, T. B. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200801968343 · Cited by 92
Tolerability and Safety of Sustained-Release Bupropion in the Management of Smoking Cessation
Aubin, H. (2002) · Drugs · doi:10.2165/00003495-200262002-00005 · Cited by 91
Harris, K. J., Okuyemi, K. S., Catley, D., Mayo, M. S., Ge, B., & Ahluwalia, J. S. (2004) · Preventive Medicine · doi:10.1016/j.ypmed.2003.12.008 · Cited by 91
Muramoto, M. L., Leischow, S. J., Sherrill, D. L., Matthews, E., & Strayer, L. J. (2007) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.161.11.1068 · Cited by 90
Nicotine patch and paroxetine for smoking cessation.
Killen, J. D., Fortmann, S. P., Schatzberg, A. F., Hayward, C., Sussman, L. K., Rothman, M. S., Strausberg, L., & Varady, A. N. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.5.883 · Cited by 89
The effects of fluoxetine combined with nicotine inhalers in smoking cessation--a randomized trial.
Blondal, T., Gudmundsson, L., Tomasson, K., Jonsdottir, D., Hilmarsdóttir, H., Kristjansson, F., Nilsson, F., & Bjornsdottir, U. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.94710076.x · Cited by 88
Two-Year Follow-Up of a Smoking Cessation Trial in Patients With Schizophrenia
Evins, A. E., Cather, C., Rigotti, N. A., Freudenreich, O., Henderson, D. C., Olm-Shipman, C. M., & GOFF, D. C. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0304 · Cited by 88
Bupropion exposures: clinical manifestations and medical outcome
Belson, M. G., & Kelley, T. R. (2002) · Journal of Emergency Medicine · doi:10.1016/s0736-4679(02)00522-x · Cited by 88
CYP2B6 and Bupropion’s Smoking-Cessation Pharmacology: The Role of Hydroxybupropion
Zhu, A. Z. X., Cox, L. S., Nollen, N. L., Faseru, B., Okuyemi, K. S., Ahluwalia, J. S., Benowitz, N. L., & Tyndale, R. F. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.186 · Cited by 88
Influences of gender and weight gain on short-term relapse to smoking in a cessation trial.
Borrelli, B., Spring, B. J., NIAURA, R. S., Hitsman, B. L., & Papandonatos, G. D. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.69.3.511 · Cited by 88
Jamerson, B. D. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80023-0 · Cited by 87
Onset of major depression during treatment for nicotine dependence
Killen, J. D., Fortmann, S. P., Schatzberg, A. F., Hayward, C., & Varady, A. N. (2003) · Addictive Behaviors · doi:10.1016/s0306-4603(01)00266-0 · Cited by 87
Effects of gender on relapse prevention in smokers treated with bupropion SR
Gonzales, D. H., Bjornson, W., Durcan, M. J., White, J. D., Johnston, J. A., Buist, A. S., Sachs, D. P. L., Rigotti, N. A., Niaura, R., Hays, J. T., et al. (2002) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(02)00419-1 · Cited by 87
Hurt, R. D., Krook, J. E., Croghan, I. T., Loprinzi, C. L., Sloan, J. A., Novotny, P. J., Kardinal, C. G., Knost, J. A., Tirona, M. T., Addo, F., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.160 · Cited by 86
Cox, L. S., Patten, C. A., NIAURA, R. S., Decker, P. A., Rigotti, N. A., Sachs, D. P. L., Buist, A. S., & Hurt, R. D. (2004) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2004.30423.x · Cited by 86
Johnston, J. A., Fiedler‐Kelly, J., Glover, E. D., Sachs, D. P. L., Grasela, T. H., & DeVeaugh-Geiss, J. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200110042852 · Cited by 86
Bupropion SR and contingency management for adolescent smoking cessation
Gray, K. M., Carpenter, M. J., Baker, N. L., Hartwell, K. J., Lewis, A. L., Hiott, D. W., Deas, D., & Upadhyaya, H. P. (2010) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2010.08.010 · Cited by 84
David, S. P., Strong, D. R., Munafo, M. R., Brown, R. A., Lloyd‐Richardson, E. E., Wileyto, E. P., Evins, A. E., Shields, P. G., Lerman, C. E., & NIAURA, R. S. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701705027 · Cited by 83
Bupropion and Cognitive Behavioral Therapy for Weight-Concerned Women Smokers
Levine, M. D., Perkins, K. A., Kalarchian, M. A., Cheng, Y., Houck, P. R., Slane, J. D., & Marcus, M. D. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.33 · Cited by 83
A bupropion smoking cessation clinical trial for cancer patients
Schnoll, R. A., Martinez, E., Tatum, K. L., Weber, D. M., Kuzla, N., Glass, M., Ridge, J. A., Langer, C. J., Miyamoto, C. T., Wileyto, E. P., et al. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9507-8 · Cited by 83
Strong, D. R., Kahler, C. W., Leventhal, A. M., Abrantes, A. M., Lloyd‐Richardson, E. E., NIAURA, R. S., & Brown, R. A. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp111 · Cited by 82
Bupropion for Smoking Cessation: A Randomized Trial
Simon, J. A., Duncan, C., Carmody, T. P., & Hudes, E. S. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.16.1797 · Cited by 81
Extended treatment with bupropion SR for cigarette smoking cessation
Killen, J. D., Fortmann, S. P., Murphy, G. M., Hayward, C., Arredondo, C., Cromp, D., Celio, M., Abe, L., Wang, Y., & Schatzberg, A. F. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.2.286 · Cited by 80
Effect of Bupropion on Depression Symptoms in a Smoking Cessation Clinical Trial.
Lerman, C. E., NIAURA, R. S., Collins, B. N., Wileyto, E. P., Audrain-McGovern, J. E., Pinto, A., Hawk, L. W., & Epstein, L. H. (2004) · Psychology of Addictive Behaviors · doi:10.1037/0893-164x.18.4.362 · Cited by 80
Bupropion SR and counseling for smoking cessation in actual practice: Predictors of outcome
Swan, G. E., Jack, L. M., Chorost, M., Javitz, H. S., Curry, S., McAfee, T. A., & Dacey, S. (2003) · Nicotine & Tobacco Research · doi:10.1080/14622200310001646903 · Cited by 80
Bupropion sustained release and smoking cessation.
Goldstein, M. G. (1998) · PubMed · Cited by 77
Efficacy of bupropion alone and in combination with nicotine gum
Piper, M. E., Federman, E. B., McCarthy, D. E., Bolt, D. M., Smith, S. S., Fiore, M. C., & Baker, T. B. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701540820 · Cited by 77
Effectiveness of Bupropion for Smoking Cessation During Pregnancy
Chan, B., Einarson, A., & Koren, G. (2005) · Journal of Addictive Diseases · doi:10.1300/j069v24n02_02 · Cited by 76
Biberman, R., Neumann, R., Katzir, I., & Gerber, Y. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00524.x · Cited by 75
Collins, B. N., Wileyto, E. P., Patterson, F., Rukstalis, M. R., Audrain-McGovern, J. E., Kaufmann, V., Pinto, A., Hawk, L. W., NIAURA, R. S., Epstein, L. H., et al. (2004) · Nicotine & Tobacco Research · doi:10.1080/14622200310001656830 · Cited by 75
Triple-Combination Pharmacotherapy for Medically Ill Smokers
Steinberg, M. B., Greenhaus, S., Schmelzer, A. C., Manderski, M. T. B., Foulds, J., Hoover, D. R., & Carson, J. L. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-7-200904070-00004 · Cited by 74
Aubin, H., Lebargy, F., Berlin, I., Bidaut-Mazel, C., Chemali‐Hudry, J., & Lagrue, G. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00814.x · Cited by 74
Croghan, I. T., Hurt, R. D., Dakhil, S. R., Croghan, G. A., Sloan, J. A., Novotny, P. J., Rowland, K. M., Bernath, A., Loots, M. L., Le-Lindqwister, N. A., et al. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60997-x · Cited by 74
Tomlinson, G. E., Tsoh, J. Y., de Moor, C., Cinciripini, L. G., Minna, J. D., Cinciripini, P. M., & Wetter, D. W. (2004) · Nicotine & Tobacco Research · doi:10.1080/14622200410001676396 · Cited by 73
A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation
Prochazka, A. V., Kick, S., Steinbrunn, C., Miyoshi, T., & Fryer, G. E. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.20.2229 · Cited by 73
Effects of Biochemically Confirmed Smoking Cessation on White Blood Cell Count
Abel, G. A., Hays, J. T., Decker, P. A., Croghan, G. A., Kuter, D. J., & Rigotti, N. A. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.8.1022 · Cited by 73
Bupropion for Smoking Cessation in Patients With Acute Coronary Syndrome
Planer, D., Lev, I., Elitzur, Y., Sharon, N. A., Ouzan, E., Pugatsch, T., Chasid, M., Rom, M., & Lotan, C. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.72 · Cited by 72
Using Extended Cognitive Behavioral Treatment and Medication to Treat Dependent Smokers
Hall, S. M., Humfleet, G. L., Muñoz, R. F., Reus, V. I., Prochaska, J. J., & Robbins, J. A. (2011) · American Journal of Public Health · doi:10.2105/ajph.2010.300084 · Cited by 71
Mood, major depression, and fluoxetine response in cigarette smokers
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.398 · Cited by 70
Javitz, H. S., Swan, G. E., Zbikowski, S. M., Curry, S. J., McAfee, T. A., Decker, D. L., Patterson, R., & Jack, L. M. (2004) · PubMed · Cited by 70
Evins, A. E., Maravić, M. C., Alpert, J. E., Pava, J. A., Liese, B. S., Farabaugh, A. H., & Fava, M. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31818ad7d6 · Cited by 69
Nicotine and bupropion share a similar discriminative stimulus effect
Young, R., & Glennon, R. A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01554-6 · Cited by 69
Differences in smoking expectancies in smokers with and without a history of major depression
Weinberger, A. H., George, T. P., & McKee, S. A. (2010) · Addictive Behaviors · doi:10.1016/j.addbeh.2010.12.024 · Cited by 68
Stapleton, J., West, R., Hájek, P., Wheeler, J., Vangeli, E., Abdi, Z., OʼGara, C., McRobbie, H. J., Humphrey, K., Ali, R. J., et al. (2013) · Addiction · doi:10.1111/add.12304 · Cited by 67
Boshier, A., Wilton, L., & Shakir, S. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0693-0 · Cited by 66
Moss, T. G., Sacco, K. A., Allen, T. M., Weinberger, A. H., Vessicchio, J. C., & George, T. P. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.04.005 · Cited by 66
Murphy, M., Johnstone, E. C., Griffiths, S., Walton, R. T., David, S. P., NIAURA, R. S., Papandonatos, G. D., Shadel, W. G., Burkholder, G. J., Britt, D. M., et al. (2003) · Nicotine & Tobacco Research · doi:10.1080/14622200310001615295 · Cited by 65
Catley, D., Harris, K. J., Okuyemi, K. S., Mayo, M. S., Pankey, E., & Ahluwalia, J. S. (2005) · Nicotine & Tobacco Research · doi:10.1080/14622200500330118 · Cited by 65
Interventions for smokeless tobacco use cessation
Ebbert, J. O., Montori, V. M., Erwin, P. J., & Stead, L. F. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004306.pub4 · Cited by 65
Self-citationBupropion for pharmacologic relapse prevention to smoking
Hurt, R. D., Wolter, T. D., Rigotti, N. A., Hays, J. T., NIAURA, R. S., Durcan, M. J., Gonzales, D. H., Sachs, D. P. L., Johnston, J. A., & Offord, K. P. (2002) · Addictive Behaviors · doi:10.1016/s0306-4603(01)00188-5 · Cited by 63
da Costa, C. L., Younes, R. N., & Lourenço, M. T. C. (2002) · CHEST Journal · doi:10.1378/chest.122.2.403 · Cited by 63
Dalsgarð, Ó. J., Hansen, N.-C. G., Søes‐Petersen, U., Evald, T., Høegholm, A., Barber, J., & Vestbo, J. (2004) · Nicotine & Tobacco Research · doi:10.1080/14622200310001656867 · Cited by 63
Cost-Benefit Analysis of Sustained-Release Bupropion, Nicotine Patch, or Both for Smoking Cessation
Nielsen, K. O., & Fiore, M. C. (2000) · Preventive Medicine · doi:10.1006/pmed.1999.0627 · Cited by 62
Hubbard, R., Lewis, S., West, J., Smith, C., Godfrey, C., Smeeth, L., Farrington, P., & Britton, J. (2005) · Thorax · doi:10.1136/thx.2005.041798 · Cited by 62
Haas, J. S., Kaplan, C. P., Barenboim, D., Jacob, P., & Benowitz, N. L. (2004) · Tobacco Control · doi:10.1136/tc.2003.004093 · Cited by 61
Myles, P. S., Leslie, K., Angliss, M., Mezzavia, P. M., & Lee, L. (2004) · Anaesthesia · doi:10.1111/j.1365-2044.2004.03943.x · Cited by 61
Independent Effects of Tobacco Abstinence and Bupropion on Cognitive Function in Schizophrenia
Evins, A. E., Deckersbach, T., Cather, C., Freudenreich, O., Maravić, M. C., Henderson, D. C., Green, M. F., Schoenfeld, D., Rigotti, N. A., & GOFF, D. C. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0915 · Cited by 60
Wagena, E. J., Knipschild, P. G., & Zeegers, M. P. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.00998.x · Cited by 60
Heterogeneity in 12‐month outcome among female and male smokers
Swan, G. E., Javitz, H. S., Jack, L. M., Curry, S. J., & McAfee, T. A. (2004) · Addiction · doi:10.1111/j.1360-0443.2003.00629.x · Cited by 59
Smoking history and motivation to quit in smokers with schizophrenia in a smoking cessation program
Mann-Wrobel, M. C., Bennett, M. E., Weiner, E., Buchanan, R. W., & Ball, M. P. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.10.030 · Cited by 59
Efficacies of dexfenfluramine and fluoxetine in preventing weight gain after smoking cessation
Spring, B. J., Wurtman, J. J., Wurtman, R. J., El-Khoury, A. E., Goldberg, H., Mcdermott, J., & Pingitore, R. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.6.1181 · Cited by 58
Aveyard, P. N., Johnson, C. J., Fillingham, S., Parsons, A. C., & Murphy, M. F. (2008) · BMJ · doi:10.1136/bmj.39545.852616.be · Cited by 58
Cost-Effectiveness of Bupropion, Nortriptyline, and Psychological Intervention in Smoking Cessation
Hall, S., Lightwood, J. M., Humfleet, G. L., Bostrom, A., Reus, V. I., & Muñoz, R. F. (2005) · The Journal of Behavioral Health Services & Research · doi:10.1007/bf02384199 · Cited by 57
Berlin, I., Chen, H., & Covey, L. S. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03109.x · Cited by 56
Saules, K. K., Schuh, L. M., Arfken, C. L., Reed, K., Kilbey, M. M., & Schuster, C. R. (2004) · American Journal on Addictions · doi:10.1080/10550490490512762 · Cited by 56
Serious Adverse Reactions of Bupropion for Smoking Cessation
Beyens, M., Guy, C., Mounier, G., Laporte, S., & Ollagnier, M. (2008) · Drug Safety · doi:10.2165/00002018-200831110-00006 · Cited by 56
A multi‐level analysis of non‐significant counseling effects in a randomized smoking cessation trial
McCarthy, D. E., Piasecki, T. M., Jorenby, D. E., Lawrence, D. L., Shiffman, S. S., & Baker, T. B. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03089.x · Cited by 56
Non-nicotine pharmacotherapies for smoking cessation
McRobbie, H. J., Lee, M.-S., & Juniper, Z. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2005.05.016 · Cited by 55
Efficacy of bupropion in the indigenous Maori population in New Zealand
Holt, S., Timu-Parata, C., Ryder-Lewis, S., Weatherall, M., & Beasley, R. (2005) · Thorax · doi:10.1136/thx.2004.030239 · Cited by 55
Covey, L. S., Glassman, A. H., Jiang, H., Fried, J., Masmela, J. R., LoDuca, C., Petkova, E., & Rodriguez, K. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01887.x · Cited by 54
Haggsträm, F. M., Chatkin, J. M., Sussenbach-Vaz, E., Cesari, D. H., Fam, C. F., & Fritscher, C. C. (2006) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2005.05.003 · Cited by 53
Predictors of cessation in African American light smokers enrolled in a bupropion clinical trial
Faseru, B., Nollen, N. L., Mayo, M. S., Krebill, R., Choi, W. S., Benowitz, N. L., Tyndale, R. F., Okuyemi, K. S., Ahluwalia, J. S., & Cox, L. S. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.11.010 · Cited by 53
Effects of selegiline (l-deprenyl) during smoking and short-term abstinence
Houtsmuller, E. J., Thornton, J. A., & Stitzer, M. L. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1152-9 · Cited by 53
Non-Nicotine Pharmacotherapy for Smoking Cessation: Mechanisms and Prospects
Benowitz, N. L., & Peng, M. W. (2000) · CNS Drugs · doi:10.2165/00023210-200013040-00004 · Cited by 52
Adapting Smoking Cessation Treatment According to Initial Response to Precessation Nicotine Patch
Rose, J. E., & Behm, F. M. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12070919 · Cited by 52
Nicotine-like discriminative stimulus effects of bupropion in rats.
Wiley, J. L., LaVecchia, K. L., Martin, B. R., & Damaj, M. I. (2002) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.10.2.129 · Cited by 52
Tryptophan and high-carbohydrate diets as adjuncts to smoking cessation therapy
Bowen, D. J., Spring, B. J., & Fox, E. A. (1991) · Journal of Behavioral Medicine · doi:10.1007/bf00846173 · Cited by 51
Gariti, P., Lynch, K. G., Alterman, A. I., Kampman, K., Xie, H., & Varillo, K. (2009) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2009.01.006 · Cited by 51
Assessment of nicotine dependence among adolescent and young adult smokers: A comparison of measures
Carpenter, M. J., Baker, N. L., Gray, K. M., & Upadhyaya, H. P. (2010) · Addictive Behaviors · doi:10.1016/j.addbeh.2010.06.013 · Cited by 50
Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking
Hatsukami, D. K., Rennard, S. I., Patel, M. K., Kotlyar, M., Malcolm, R. J., Nides, M. A., Dozier, G., Bars, M. P., & Jamerson, B. D. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.07.018 · Cited by 50
The effect of five smoking cessation pharmacotherapies on smoking cessation milestones.
Japuntich, S. J., Piper, M. E., Leventhal, A. M., Bolt, D. M., & Baker, T. B. (2011) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0022154 · Cited by 50
Recycling with nicotine patches in smoking cessation
TØNNESEN, P., NØRREGAARD, J., SÄWE, U., & SIMONSEN, K. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02060.x · Cited by 48
Cited by
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Chaikof, E. L., Dalman, R. L., Eskandari, M. K., Jackson, B. M., Lee, W. A., Mansour, M. A., Mastracci, T. M., Mell, M., Murad, M. H., Nguyen, L. L., et al. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.10.044 · Cited by 2,751
Authors/Task Force Members, Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316653709 · Cited by 1,334
Anthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D., Ascher, J., Russ, C., Krishen, A., & Evins, A. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30272-0 · Cited by 1,177
Electronic cigarettes for smoking cessation
Hartmann-Boyce, J., McRobbie, H., Bullen, C., Begh, R., Stead, L. F., & Hajek, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub3 · Cited by 1,002
Self-citation
Metadata
- Authors
- Hughes, J. R., Stead, L. F., Hartmann-Boyce, J., Cahill, K., & Lancaster, T.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2014-01-08
- Issue
- 1
- Pages
- CD000031-CD000031
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W4210565407
- Cited by
- 348
- References
- 326
- FWCI
- 32.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.